Antiretroviral therapy (ART) is a vital treatment that helps prevent a pregnant woman from passing HIV to her baby, but one type of ART medication may increase the risk the child will develop a neurological condition, according to new research being presented at IDWeek 2018.
Teens and young adults who have injected drugs are at risk for contracting hepatitis C, but most aren’t tested and therefore don’t receive life-saving treatment, according to a national study being presented at IDWeek 2018. The study of more than 250,000 at-risk youth found only one-third of those with diagnosed opioid use disorder (OUD) were tested for hepatitis C.
Among the nine exceptional individuals being honored by the Infectious Diseases Society of America (IDSA) and the IDSA Foundation at IDWeek 2018 in San Francisco, Richard Whitley is the recipient of the Alexander Fleming Award for lifetime achievement.
IDSA is pleased to welcome Dr. Sears along with four new members to the Board of Directors to continue to elevate the field of ID.
Medicare A/B Contractor Palmetto GBA recently finalized its draft local coverage determination (LCD) for Multiplex Nucleic Acid Amplified Tests for Respiratory Viral Panels (L37713), effective Nov. 12.
The United Nations General Assembly’s first high-level meeting on tuberculosis this week opens the opportunity for international collaboration and commitment toward ending the impacts of the world’s leading infectious disease killer.
The reauthorization of the Pandemic and All Hazards Preparedness Act (PAHPA) approved by the House of Representatives today includes measures that are critical to ensure that our nation has the resources and expertise needed to confront, control and combat emerging public health threats.
Showing a more than 100 percent increase in the numbers of infants affected by syphilis during the last five years, unprecedented incidence of syphilis, gonorrhea and chlamydia, and the spread of gonorrhea resistant to multiple treatments, the 2017 STD Surveillance Report released by the Centers for Disease Prevention and Control today represents a call for immediate and responsive action.
The Infectious Diseases Society of America today joined the United States Centers for Disease Control and Prevention in a yearlong challenge to promote and support investments, innovations, and strategies against the growing global threat of antimicrobial resistance.
The administration’s transfer of funds from infectious diseases prevention, care and biomedical research programs to offset the rising costs of the “Unaccompanied Alien Children” program comes as our nation prepares for flu season and confronts unprecedented increases in cases of sexually transmitted diseases, spikes in infections linked to the opioid crisis.
Leaders of research and programmatic responses to HIV globally gathered on Capitol Hill Thursday to celebrate the 15th anniversary of the President’s Emergency Plan for AIDS Relief launch and the flagship program’s achievements, but also to cite urgent needs to strengthen and accelerate the program’s efforts toward ending the pandemic.
The U.S. Senate voted overwhelmingly last night to approve the Opioids Crisis Response Act of 2018 – their version of the comprehensive legislation (HR 6) passed by the U.S. House of Representatives in June.